What is COCH's market cap?

$55.10M, based on the Nov 4 close of $7.12.

Does Envoy Medical pay a dividend?

No regular cash dividend has been paid in the last year.

How much of COCH is sold short?

577.1K shares, 1.2% of float, as of Oct 15, 2026.

What sector is COCH in?

Healthcare, in the Orthopedic & Surgical Supplies industry.

NASDAQ · COCHHealthcareOrthopedic & Surgical Supplies

Envoy Medical, Inc. Class A Common Stock (COCH)

$7.12+7.55%

Close Nov 4, 2026 · split-adjusted

Nov 4, 2026$7.12▼ 1.82% in range

Nov 4, 2025Low $3.90 · High $59.55Nov 4, 2026

What changed · written from our data

As of Nov 4, 2026

Envoy Medical closed at $7.12 on Nov 4, up 7.55%, 88.0% below its 52-week closing high. Volume of 20.9K shares was 0.30× its 20-day average (below normal).

Split-adjusted performance: +9.3% over one month, +5.4% over six months, -6.8% over one year.

In the quarter ended Jun 30, 2026, revenue was $51K, down 34.6% from a year earlier, with a net margin of -14258.8%.

Short interest was 577.1K shares at the Oct 15 settlement, up 15.9% from the prior report (1.2% of float, 7.5 days to cover).

Market cap$55.1M7.7M shares

Revenue · quarter$51.0K−34.6% YoY

Diluted EPS$-0.70—

P/E · TTM—P/S 266.2×

Net margin-14,258.8%Gross -445.1%

Dividend yieldNone

52-week range3.90 – 59.55−88.0% from high

Volume20.9K0.30× 20-day avg

Volatility · 60d656.6%Annualised

Short % of float1.2%7.5 days to cover

Net cash$19.7MCash $19.7M

Next earnings—Not scheduled

Split-adjusted performance

1W +6.9%1M +9.3%3M +4.6%6M +5.4%YTD +7.7%1Y −6.8%3Y −40.7%5Y —

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Orthopedic & Surgical Supplies

Percentile among 22 companies (100 = best)

6-month momentum60

Revenue growth0

Net margin0

Value (low P/E)—

Size19

Industry medians: 6-month return +1.5%, revenue growth +12.8%, net margin −2.8%, P/E 29.2×.

Short interest

Details →

Shares short577.1K+15.9% vs prior

Days to cover7.5Settled Oct 15

% of float1.2%

Short vol. 10d57.8%of daily volume

Closest peers by size in Orthopedic & Surgical Supplies

Company	Price	Today	6M	Rev. growth	Net margin	P/E	Mkt cap
COCHEnvoy Medical	$7.12	+7.55%	+5.4%	−34.6%	−14258.8%	—	$55.1M
APTAlpha Pro Tech	$5.74	+3.24%	+22.1%	+12.0%	9.8%	13.9	$58.6M	Compare
MYOMyomo	$1.30	+1.56%	+52.4%	+21.3%	−34.4%	—	$51.5M	Compare
SPAISafe Pro Group	$3.05	−3.79%	−31.8%	+1336.2%	−237.9%	—	$62.1M	Compare
CNXUConexeu Sciences	$2.22	−6.72%	—	—	—	—	$68.4M	Compare
NTRBNutriband	$6.08	−3.34%	+53.1%	−29.7%	−201.3%	—	$73.9M	Compare
LAKELakeland Industries	$8.93	−0.11%	−7.3%	−4.5%	−9.8%	—	$88.7M	Compare
MLSSMilestone Scientific	$0.3290	+8.26%	−18.4%	+22.3%	−37.3%	—	$29.8M	Compare
LFWDLifeward	$6.06	+3.95%	−13.4%	+15.7%	−173.9%	—	$17.2M	Compare

News about Envoy Medical

All news →

No recent articles focused on Envoy Medical.

Quick answers

What does Envoy Medical do?: Envoy Medical Inc is a hearing health company focused on providing medical technologies across the hearing loss spectrum. Its product portfolio comprises: the Esteem FI-AMEI, a fully implanted active middle ear implant (FI -AMEI) that works with the ear's natural anatomy, and is FDA-approved for adults with moderate to severe sensorineural hearing loss; and Acclaim CI, an investigational cochlear implant under development.
What is COCH's market cap?: $55.10M, based on the Nov 4 close of $7.12.
Does Envoy Medical pay a dividend?: No regular cash dividend has been paid in the last year.
How much of COCH is sold short?: 577.1K shares, 1.2% of float, as of Oct 15, 2026.
What sector is COCH in?: Healthcare, in the Orthopedic & Surgical Supplies industry.

About Envoy Medical

Envoy Medical Inc is a hearing health company focused on providing medical technologies across the hearing loss spectrum. Its product portfolio comprises: the Esteem FI-AMEI, a fully implanted active middle ear implant (FI -AMEI) that works with the ear's natural anatomy, and is FDA-approved for adults with moderate to severe sensorineural hearing loss; and Acclaim CI, an investigational cochlear implant under development. The company derives all of its revenue substantially from the sale of the Esteem FI-AMEI implants and their replacement components. It has one reportable segment: hearing.

HQ: White Bear Lake, MN47 employeesListed Oct 2, 2023envoymedical.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology